BDBM345999 N-(2-Dimethylamino-ethyl)-2-(4-ethyl-2,3,4,5-tetrahydro-benzo[f][1,4]oxazepin-9-ylamino)-N-(2-trifluoromethyl-thiazol-5-ylmethyl)-acetamide::US10202368, Example 76
SMILES: CCN1CCOc2c(C1)cccc2NCC(=O)N(CCN(C)C)Cc1cnc(s1)C(F)(F)F
InChI Key: InChIKey=SHUAXPOVHCEWNS-UHFFFAOYSA-N
Data: 1 EC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
C-X-C chemokine receptor type 7 (CXCR7) (Homo sapiens (Human)) | BDBM345999![]() (N-(2-Dimethylamino-ethyl)-2-(4-ethyl-2,3,4,5-tetra...) | Reactome pathway UniProtKB/SwissProt antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 430 | n/a | n/a | n/a | n/a |
IDORSIA PHARMACEUTICALS Ltd US Patent | Assay Description The assay is using the PathHunter CHO-K1 CXCR7 β-arrestin cell line from DiscoverX. The system is based on the Enzyme Fragment Complementation T... | US Patent US10202368 (2019) BindingDB Entry DOI: 10.7270/Q2ZK5JRJ | |||||||||||
More data for this Ligand-Target Pair |